2023 Oncology Guide to Patient Support Services

Rigel Pharmaceuticals offers the Rigel OneCare patient support program to assist patients while taking Tavalisse. Read More ›

Sandoz, a Novartis Division, offers the Sandoz One Source patient support program to assist patients while taking Zarxio or Ziextenzo. Read More ›

Sanofi offers the CareASSIST Program to assist patients prescribed certain Sanofi medications. Read More ›

Seagen offers the Seagen Secure patient assistance program to help patients while taking a Seagen oncology medication. Read More ›

Secura Bio offers the Secura Care Patient Support Program to assist patients while taking Copiktra. Read More ›

The ServierONE patient support program provides patients with financial assistance and one-on-one support when prescribed a Servier oncology product. Read More ›

Spectrum Pharmaceuticals offers the Access4Me program to provide access and reimbursement support to patients who have been prescribed Rolvedon. Read More ›

Sun Pharma offers the Yonsa Support program and the Odomzo Support program to help patients while taking these medications. Read More ›

Sobi offers the Doptelet Connect program to provide access and reimbursement support to patients who have been prescribed Doptelet. Read More ›

Taiho Oncology offers the Taiho Oncology Patient Support program to help patients while taking Inqovi, Lonsurf, or Lytgobi. Read More ›

Takeda Oncology offers the Here2Assist support program to help patients who are prescribed a Takeda Oncology treatment. Read More ›

TerSera Therapeutics offers the TerSera SupportSource program to help patients while taking a TerSera oncology medicine. Read More ›

Teva Oncology offers the Comprehensive Oncology Reimbursement Expertise (CORE) program and the Teva Cares Foundation Patient Assistance Program to help patients while taking a Teva Oncology treatment. Read More ›

UroGen Pharma offers the UroGen Support program to assist patients while taking Jelmyto. Read More ›

Viatris offers the Viatris Advocate program to provide continuous access and support to patients who have been prescribed Fulphila or Ogivri. Read More ›